Our guest is Sergey Jakimov, the Founding and Managing Partner of LongeVC, a venture capital firm dedicated to backing early-stage biotech and longevity startups. A serial entrepreneur, Sergey has co-founded ventures like Longenesis, a medical tech startup unlocking biomedical data for drug discovery, and the Longevity Science Foundation, a non-profit advancing healthy human lifespan. He’s been named to Forbes Latvia's 30 Under 30 in technology and healthcare, and via LongeVC, he invests in innovation in areas including therapeutics, diagnostics, and personalized medicine.In this episode, Sergey warns about the rising danger of misinformation disguised as health advice—where influencers and hype outpace evidence-based science. I hope you enjoy our discussion as we unpack this public health challenge and explore solutions for a more credible biotech landscape.01:22           Meet Sergey Jakimov06:14           Developing a longevity focus10:47           A typical day at LongeVC13:26           The LongeVC portfolio17:28           Misinformation as health crisis26:04           The harm of bad advice33:16           The impact on biotech industry funding36:18           Strategies for addressing misinformation42:17           Optimism about trends in longevityInterested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletterTo dive deeper into the topic: 13 anti-aging startups on a mission to extend livesTurning back time with cellular reprogramming: Shift raises $16 million in seed fundingAre European biotech VCs under pressure to scale? Time to get pragmatic